HomeCompareMOTUY vs PFE

MOTUY vs PFE: Dividend Comparison 2026

MOTUY yields 14.93% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MOTUY wins by $6969052.38M in total portfolio value
10 years
MOTUY
MOTUY
● Live price
14.93%
Share price
$6.33
Annual div
$0.95
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6969052.43M
Annual income
$6,880,530,715,034.53
Full MOTUY calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — MOTUY vs PFE

📍 MOTUY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMOTUYPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MOTUY + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MOTUY pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MOTUY
Annual income on $10K today (after 15% tax)
$1,269.20/yr
After 10yr DRIP, annual income (after tax)
$5,848,451,107,779.35/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, MOTUY beats the other by $5,848,451,085,459.45/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MOTUY + PFE for your $10,000?

MOTUY: 50%PFE: 50%
100% PFE50/50100% MOTUY
Portfolio after 10yr
$3484526.24M
Annual income
$3,440,265,370,646.62/yr
Blended yield
98.73%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

MOTUY
No analyst data
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MOTUY buys
0
PFE buys
0
No recent congressional trades found for MOTUY or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMOTUYPFE
Forward yield14.93%6.13%
Annual dividend / share$0.95$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%13.2%
Portfolio after 10y$6969052.43M$49.6K
Annual income after 10y$6,880,530,715,034.53$26,258.71
Total dividends collected$6963128.64M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: MOTUY vs PFE ($10,000, DRIP)

YearMOTUY PortfolioMOTUY Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$13,686$2,986.34$9,153$693.39+$4.5KMOTUY
2$22,284$7,639.65$8,593$849.25+$13.7KMOTUY
3$47,094$23,250.18$8,336$1,066.78+$38.8KMOTUY
4$142,233$91,842.80$8,437$1,384.80+$133.8KMOTUY
5$670,663$518,473.62$9,013$1,875.40+$661.6KMOTUY
6$5,287,183$4,569,573.33$10,306$2,680.72+$5.28MMOTUY
7$72,992,399$67,335,112.49$12,820$4,101.38+$72.98MMOTUY
8$1,815,666,955$1,737,565,088.81$17,673$6,826.70+$1815.65MMOTUY
9$82,730,577,258$80,787,813,615.49$27,543$12,591.86+$82730.55MMOTUY
10$6,969,052,432,700$6,880,530,715,034.53$49,560$26,258.71+$6969052.38MMOTUY

MOTUY vs PFE: Complete Analysis 2026

MOTUYStock

Motus Holdings Limited operates in the automotive sector in South Africa and internationally. It operates through four segments: Import and Distribution, Retail and Rental, Mobility Solutions, and Aftermarket Parts. The Import and Distribution segment imports and distributes passenger and light commercial vehicles (LCV), as well as its parts to a network of dealerships, car rental companies, fleets, and government institutions. The Retail and Rental segment sells new and pre-owned passenger and commercial vehicles in various segments, as well as rents passenger and LCVs. It has 23 original equipment manufacturers (OEMs) through 345 dealerships, including 104 pre-owned, 206 passenger vehicle, and 36 commercial vehicle dealerships in South Africa; and 19 OEMs through 115 dealerships comprising 82 commercial and 33 passenger dealerships in the United Kingdom, as well as 20 OEMs through 36 passenger dealerships in Australia. This segment also rents cars under the Europcar and Tempest brands; sells parts and accessories; and engages in servicing and maintenance of vehicles. The Mobility Solutions segment develops, manages, sells, and administers service, maintenance, and warranty plans; and provides value added products and services, business process outsourcing, and fleet management services. This segment also develops and distributes various vehicle-related financial products and services through importers, distributors, dealers, finance houses, call centers, and digital channels. The Aftermarket Parts segment distributes, wholesales, and retails parts, accessories, and aftermarket parts for out-of-warranty vehicles through retail and franchised stores, and specialized workshops. This segment operates 564 retail stores, including 102 owned stores in South Africa, Taiwan, China, and the United Kingdom. It is also involved in the property investment activities. The company was founded in 1948 and is based in Bedfordview, South Africa.

Full MOTUY Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this MOTUY vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MOTUY vs SCHDMOTUY vs JEPIMOTUY vs OMOTUY vs KOMOTUY vs MAINMOTUY vs JNJMOTUY vs MRKMOTUY vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.